G, T. (2026). Lessons learned: Use of 24-hour ambulatory esophageal and gastric pH monitoring and its implications for proton pump inhibitor use in cancer patients requiring oral oncologic therapies. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 39(4), . https://doi.org/10.1093/dote/doag073
Chicago Style (17th ed.) CitationG, Triadafilopoulos. "Lessons Learned: Use of 24-hour Ambulatory Esophageal and Gastric PH Monitoring and Its Implications for Proton Pump Inhibitor Use in Cancer Patients Requiring Oral Oncologic Therapies." Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus 39, no. 4 (2026). https://doi.org/10.1093/dote/doag073.
MLA (9th ed.) CitationG, Triadafilopoulos. "Lessons Learned: Use of 24-hour Ambulatory Esophageal and Gastric PH Monitoring and Its Implications for Proton Pump Inhibitor Use in Cancer Patients Requiring Oral Oncologic Therapies." Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus, vol. 39, no. 4, 2026, https://doi.org/10.1093/dote/doag073.
